Baxter clears violations from clogged filter warning letter

Baxter has resolved manufacturing issues cited in an FDA warning letter concerning clogged filters at a plant in Belgium, where it makes immune-system treatment Gammagard. Issues concerned how the company investigated and handled the matter. Closeout letter | Warning letter

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.